Pharmacokinetics of mycophenolic acid (MEPA) and its glucuronide metabolite (MPAG) in liver Tx in combination therapy with tacrolimus, with or without steroids

被引：0
|
作者：
Regazzi, M
Molinaro, M
Montagna, M
Bartoli, A
Cusato, M
Arienti, B
De Simone, A
Reggiani, P
机构：
[1] Policlin San Matteo, IRCCS, Dept Pharmacol, I-27100 Pavia, Italy
[2] Osped Maggiore, IRCCS, Liver & Lung Transplant Ctr, Milan, Italy
来源：
THERAPEUTIC DRUG MONITORING | 2003年 / 25卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
198
引用
收藏
页码：535 / 535
页数：1
相关论文
共 27 条
  • [21] Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies
    Jiao, Zheng
    Zhong, Jian-yong
    Zhang, Ming
    Shi, Xiao-jin
    Yu, Yun-qiu
    Lu, Wei-yue
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (01) : 27 - 37
  • [22] Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies
    Zheng Jiao
    Jian-yong Zhong
    Ming Zhang
    Xiao-jin Shi
    Yun-qiu Yu
    Wei-yue Lu
    European Journal of Clinical Pharmacology, 2007, 63 : 27 - 37
  • [23] Pharmacokinetics of Mycophenolic Acid and Its Glucuronide Metabolites in Stable Adult Liver Transplant Recipients With Renal Dysfunction on a Low-Dose Calcineurin Inhibitor Regimen and Mycophenolate Mofetil
    Beckebaum, Susanne
    Armstrong, Victor W.
    Cicinnati, Vito Rosario
    Streit, Frank
    Klein, Christian Georg
    Gerken, Guido
    Paul, Andreas
    Oellerich, Michael
    THERAPEUTIC DRUG MONITORING, 2009, 31 (02) : 205 - 210
  • [24] Time-Related Clinical Determinants of Long-Term Tacrolimus Pharmacokinetics in Combination Therapy with Mycophenolic Acid and CorticosteroidsA Prospective Study in One Hundred De Novo Renal Transplant Recipients
    Dirk R. J. Kuypers
    Kathleen Claes
    Pieter Evenepoel
    Bart Maes
    Willy Coosemans
    Jacques Pirenne
    Yves Vanrenterghem
    Clinical Pharmacokinetics, 2004, 43 : 741 - 762
  • [25] Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids -: A prospective study in one hundred de novo renal transplant recipients
    Kuypers, DRJ
    Claes, K
    Evenepoel, P
    Maes, B
    Coosemans, W
    Pirenne, J
    Vanrenterghem, Y
    CLINICAL PHARMACOKINETICS, 2004, 43 (11) : 741 - 762
  • [26] The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals
    Geng, Fang
    Jiao, Zheng
    Dao, Yi-Jun
    Qiu, Xiao-Yan
    Ding, Jun-Jie
    Shi, Xiao-Jin
    Li, Zhong-Dong
    Zhong, Ming-Kang
    CLINICA CHIMICA ACTA, 2012, 413 (7-8) : 683 - 690
  • [27] It matters to monitor drug levels -: Effects of calcineurin inhibitors on pharmacokinetics of mycophenolic acid and its glucuronide metabolite during the maintenance period following renal transplantation.: !Naito T, !Shinno K, !Maeda T, !Kagawa Y, !Hashimoto H, !Otsuka A, !Takayama T, !Ushiyama T, !Suzuki K, !Ozono S Biol Pharm Bull 2006;29:275-280.
    Perkins, JD
    LIVER TRANSPLANTATION, 2006, 12 (07) : 1169 - 1170
123